The 2020 ROBINSCA trial, a randomized controlled population-based study in the Netherlands, evaluated the effectiveness of coronary artery calcium (CAC) scoring versus traditional risk factor assessment (SCORE model) for cardiovascular disease (CVD) screening in asymptomatic adults. Participants were randomized into three groups: control (usual care), SCORE-based screening, and CAC-based screening.
